These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36516224)
1. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224 [TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Lawrence WR; Lim JE; Huang J; Sampson JN; Weinstein SJ; Albanes D Eur J Clin Nutr; 2022 Sep; 76(9):1254-1265. PubMed ID: 35322169 [TBL] [Abstract][Full Text] [Related]
3. Metabolomic Profiling of Serum Retinol in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Huang J; Panagiotou OA; Anic GM; Mondul AM; Liao LM; Derkach A; Stolzenberg-Solomon R; Weinstein SJ; Albanes D Sci Rep; 2017 Sep; 7(1):10601. PubMed ID: 28878287 [TBL] [Abstract][Full Text] [Related]
7. Diabetes and branched-chain amino acids: What is the link? Bloomgarden Z J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529 [TBL] [Abstract][Full Text] [Related]
8. Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort. Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Liao LM; Gu F; Mondul AM; Sampson JN; Albanes D Am J Epidemiol; 2018 Aug; 187(8):1721-1732. PubMed ID: 29390044 [TBL] [Abstract][Full Text] [Related]
9. Prospective serum metabolomic profiling of lethal prostate cancer. Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128 [TBL] [Abstract][Full Text] [Related]
10. Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Mondul AM; Sampson JN; Moore SC; Weinstein SJ; Evans AM; Karoly ED; Virtamo J; Albanes D Am J Clin Nutr; 2013 Aug; 98(2):488-93. PubMed ID: 23803886 [TBL] [Abstract][Full Text] [Related]
11. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191 [TBL] [Abstract][Full Text] [Related]
12. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study. Al-Akl NS; Khalifa O; Ponirakis G; Parray A; Ramadan M; Khan S; Chandran M; Ayadathil R; Elsotouhy A; Own A; Al Hamad H; Decock J; Alajez NM; Albagha O; Malik RA; El-Agnaf OMA; Arredouani A Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396924 [TBL] [Abstract][Full Text] [Related]
13. Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults. Yu D; Moore SC; Matthews CE; Xiang YB; Zhang X; Gao YT; Zheng W; Shu XO Metabolomics; 2016 Jan; 12():. PubMed ID: 27840598 [TBL] [Abstract][Full Text] [Related]
14. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats. Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845 [TBL] [Abstract][Full Text] [Related]
15. Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes. Guasch-Ferré M; Santos JL; Martínez-González MA; Clish CB; Razquin C; Wang D; Liang L; Li J; Dennis C; Corella D; Muñoz-Bravo C; Romaguera D; Estruch R; Santos-Lozano JM; Castañer O; Alonso-Gómez A; Serra-Majem L; Ros E; Canudas S; Asensio EM; Fitó M; Pierce K; Martínez JA; Salas-Salvadó J; Toledo E; Hu FB; Ruiz-Canela M Am J Clin Nutr; 2020 Apr; 111(4):835-844. PubMed ID: 32060497 [TBL] [Abstract][Full Text] [Related]
16. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects. Abu Bakar MH; Sarmidi MR Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959 [TBL] [Abstract][Full Text] [Related]
17. Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics. Zhang F; Chen X; Yang M; Shen X; Wang Y; Zhong D; Zeng F; Jin R PLoS One; 2024; 19(3):e0300593. PubMed ID: 38517904 [TBL] [Abstract][Full Text] [Related]
18. Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival. Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Mondul AM; Sampson JN; Albanes D J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):853-859. PubMed ID: 29878065 [TBL] [Abstract][Full Text] [Related]
19. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants. Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466 [TBL] [Abstract][Full Text] [Related]
20. Metabolomics of Type 1 and Type 2 Diabetes. Arneth B; Arneth R; Shams M Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]